Wales

Drug manufacturing
#AstraZeneca #England #Hyperkalaemia #Wales

Access to hyperkalaemia drug expands across England and Wales 

Access to AstraZeneca’s hyperkalaemia treatment Lokelma has been expanded across England and Wales.  AstraZeneca announced the National Institute for Health and Care Excellence (NICE) had issued a draft recommendation for lokelma (sodium zirconium cyclosilicate). Under the new willingness-to-pay threshold, more than double the number of patients could be eligible for… Read More

#News #Regulatory

#Biomanufacturing #HUB Organoids #Molecular Devices #Organoids #UK #Wales

UK facility to manufacture organoids for drug discovery

A new facility has opened in Cardiff, UK designed to manufacture patient-derived organoids (PDOs) at scale for use in drug discovery and development. The multi-million-pound facility was custom-built by Molecular Devices to house its bioprocess workflow and bioreactor technology Mary Duseau, President of Molecular… Read More

#News

GBP pound sterling funding
#CatSci #Funding #Oligonucleotides #RNA sequencing #Wales

CatSci wins Welsh grant for oligonucleotides development

CatSci has won a Welsh Government SMART Capital Equipment Fund grant to enhance its oligonucleotides capability. The grant will enable the company to invest in new equipment that will increase the rapid creation of a large pool of candidates of RNA/DNA sequences. Production of oligonucleotides is currently both slow and… Read More

#Business & Investment #News